Avid Bioservices Stock Fundamentals
| CDMO Stock | USD 12.35 0.02 0.16% |
Avid Bioservices fundamentals help investors to digest information that contributes to Avid Bioservices' financial success or failures. It also enables traders to predict the movement of Avid Stock. The fundamental analysis module provides a way to measure Avid Bioservices' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avid Bioservices stock.
Avid |
Avid Bioservices Company Operating Margin Analysis
Avid Bioservices' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Avid Bioservices Operating Margin | (0.06) % |
Most of Avid Bioservices' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avid Bioservices is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Avid Bioservices has an Operating Margin of -0.0611%. This is 99.83% lower than that of the Biotechnology sector and 99.95% lower than that of the Health Care industry. The operating margin for all United States stocks is 98.89% lower than that of the firm.
Avid Bioservices Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Avid Bioservices's current stock value. Our valuation model uses many indicators to compare Avid Bioservices value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avid Bioservices competition to find correlations between indicators driving Avid Bioservices's intrinsic value. More Info.Avid Bioservices is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avid Bioservices' earnings, one of the primary drivers of an investment's value.Avid Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avid Bioservices' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avid Bioservices could also be used in its relative valuation, which is a method of valuing Avid Bioservices by comparing valuation metrics of similar companies.Avid Bioservices is currently under evaluation in operating margin category among its peers.
Avid Fundamentals
| Return On Equity | -1.16 | ||||
| Return On Asset | -0.0305 | ||||
| Profit Margin | (1.01) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 962.43 M | ||||
| Shares Outstanding | 63.96 M | ||||
| Shares Owned By Insiders | 1.13 % | ||||
| Shares Owned By Institutions | 98.87 % | ||||
| Number Of Shares Shorted | 11.72 M | ||||
| Price To Earning | 10.76 X | ||||
| Price To Book | 13.45 X | ||||
| Price To Sales | 5.55 X | ||||
| Revenue | 139.91 M | ||||
| Gross Profit | 31.48 M | ||||
| EBITDA | (11.48 M) | ||||
| Net Income | (140.75 M) | ||||
| Cash And Equivalents | 115.14 M | ||||
| Cash Per Share | 1.85 X | ||||
| Total Debt | 207.83 M | ||||
| Debt To Equity | 1.02 % | ||||
| Current Ratio | 1.93 X | ||||
| Book Value Per Share | 0.92 X | ||||
| Cash Flow From Operations | 10.95 M | ||||
| Short Ratio | 3.79 X | ||||
| Earnings Per Share | (2.29) X | ||||
| Price To Earnings To Growth | 16.30 X | ||||
| Target Price | 12.75 | ||||
| Number Of Employees | 371 | ||||
| Beta | 1.41 | ||||
| Market Capitalization | 789.85 M | ||||
| Total Asset | 336.56 M | ||||
| Retained Earnings | (571.87 M) | ||||
| Working Capital | 33.44 M | ||||
| Current Asset | 25.65 M | ||||
| Current Liabilities | 10.9 M | ||||
| Net Asset | 336.56 M |
About Avid Bioservices Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avid Bioservices's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avid Bioservices using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avid Bioservices based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California. Avid Bioservices operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 321 people.
Pair Trading with Avid Bioservices
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avid Bioservices position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will appreciate offsetting losses from the drop in the long position's value.Moving together with Avid Stock
Moving against Avid Stock
| 0.71 | VERU | Veru Inc Earnings Call This Week | PairCorr |
| 0.6 | EQ | Equillium | PairCorr |
| 0.53 | VALN | Valneva SE ADR | PairCorr |
| 0.5 | VIGL | Vigil Neuroscience | PairCorr |
| 0.47 | DNTH | Dianthus Therapeutics | PairCorr |
The ability to find closely correlated positions to Avid Bioservices could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avid Bioservices when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avid Bioservices - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avid Bioservices to buy it.
The correlation of Avid Bioservices is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avid Bioservices moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avid Bioservices moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avid Bioservices can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Avid Bioservices Piotroski F Score and Avid Bioservices Altman Z Score analysis. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avid Bioservices. If investors know Avid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avid Bioservices listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Avid Bioservices is measured differently than its book value, which is the value of Avid that is recorded on the company's balance sheet. Investors also form their own opinion of Avid Bioservices' value that differs from its market value or its book value, called intrinsic value, which is Avid Bioservices' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avid Bioservices' market value can be influenced by many factors that don't directly affect Avid Bioservices' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avid Bioservices' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avid Bioservices is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avid Bioservices' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.